Selection of DNA Aptamers for Ovarian Cancer Biomarker CA125 Using One-Pot SELEX and High-Throughput Sequencing
CA125 is a mucin glycoprotein whose concentration in serum correlates with a woman’s risk of developing ovarian cancer and also indicates response to therapy in diagnosed patients. Accurate detection of this large, complex protein in patient samples is of great clinical relevance. We suggest that po...
Saved in:
Main Authors: | Delia J. Scoville, Tae Kyu Brian Uhm, Jamie A. Shallcross, Rebecca J. Whelan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Journal of Nucleic Acids |
Online Access: | http://dx.doi.org/10.1155/2017/9879135 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Capture-SELEX: Selection of DNA Aptamers for Aminoglycoside Antibiotics
by: Regina Stoltenburg, et al.
Published: (2012-01-01) -
Preparation of a Specific ssDNA Aptamer for Brevetoxin-2 Using SELEX
by: Rui-Yun Tian, et al.
Published: (2016-01-01) -
TB Peritonitis Mistaken for Ovarian Carcinomatosis Based on an Elevated CA-125
by: Joseph D. Boss, et al.
Published: (2012-01-01) -
Elevated CA 125 in a CASE of Leaking Endometrioma
by: Svetha Rao, et al.
Published: (2018-01-01) -
Assessment of Diagnostic Values among CA-125, RMI, HE4, and ROMA for Cancer Prediction in Women with Nonfunctional Ovarian Cysts
by: Shina Oranratanaphan, et al.
Published: (2018-01-01)